- Global Pharma News & Resources

The Global Single-use Bioprocessing Market is Projected to Reach $26.9 Billion by 2025 - Led by, Sartorius, GE Healthcare, Eppendorf and Lonza -

The "Single-use Bioprocessing Market Size, Share, & Trends Analysis Report By Product (Simple & Peripheral Elements, Apparatus & Plants, Work Equipment), By Workflow, By End Use, And Segment Forecasts, 2018 - 2025" report has been added to's offering.

The global single-use bioprocessing market size is expected to reach USD 26.89 billion by 2025, exhibiting a CAGR of 13.6% during the forecast period. Low cost associated with operations and construction is recognized as the key factor stimulating the sales of and demand for disposable products. In addition, integration of single-use technology (SUTs) in continuous bioprocess engineering is anticipated to fuel the usage of disposables.

Rising pressure to meet the growing demand for biopharmaceuticals is expected to significantly impact the adoption of SUTs within the bioprocessing industry. Hence, this space is also expected to be benefitted by the rapid growth of biologics. Moreover, SUT helps in enhancing operational capacity, which in turn, prompts biopharmaceutical companies to adopt disposable equipment.

Key Findings

  • By product, simple and peripheral elements dominated the market as a result of wide usage in upstream biopharmaceutical production.
  • The apparatus and plants segment is expected to grow at a lucrative pace primarily due to enormous investments in the development of single-use bioreactors (SUBs) and filtration systems.
  • By workflow, the upstream segment is fueled by successful implementation of single-use systems (SUSs) in upstream processing as well as continuous introduction of new products to simplify these processes.
  • On the basis of end use, biopharmaceutical manufacturers dominated the market, with CMOs & CROs accounting for a majority of the share. This is majorly due to continuous expansion of single-use manufacturing facilities by CMOs.
  • Key players include Sartorius AG, GE Healthcare, Eppendorf AG, and Lonza. Firms are engaged in replacing traditional bioprocessing product lines with new SUTs products.
Market Dynamics Drivers
  • Several Advantages Associated With the Implementation of SUS in Overall Biomanufacturing Process
  • Widespread Adoption of Single-Use Technology Amongst CMOs
  • Investments Continue to Take Place for Expansion of cGMP Manufacturing
  • Commercial Success of Biopharmaceuticals and Consequent Increased Demand for the Biopharmaceuticals
  • High Cost of Single-Use Equipment
  • Concern of Leachables and Extractables
  • Limited Adoption in Downstream Processing

Topics Covered

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Single-use Bioprocessing Market Variables, Trends & Scope

Chapter 4 Single-use Bioprocessing Market: Product Estimates & Trend Analysis

Chapter 5 Single-use Bioprocessing Market: Workflow Estimates & Trend Analysis

Chapter 6 Single-use Bioprocessing Market: End-use Estimates & Trend Analysis

Chapter 7 Single-use Bioprocessing Market: Regional Estimates & Trend Analysis

Chapter 8 Competitive Landscape

  • General Electric Company (GE healthcare)
  • Eppendorf AG
  • Corning Incorporated
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • JM Bioconnect
  • Merck KGaA
  • Boehringer Ingelheim GmbH
  • Infors AG
  • PBS Biotech, Inc
  • Entegris, Inc.
  • Danaher Corporation
  • Kuhner AG
  • Meissner Filtration Products, Inc.
  • Rentschler Biopharma SE

For more information about this report visit

View source version on

Editor Details

Last Updated: 07-Nov-2018